Some of you may know that I have always wondered why Nicole was at a risser 0 even though she has her period. Well, first of all, I do not know her risser at this time because we haven't been to the ortho in 5 months. Second of all, a year ago, according to her hand x-ray, the ortho at Shriner's said she was a 0-1. The ortho in Montreal said she was a 0 based on the x-ray of her spine.
Anyway, I came across an article today from American Family Physician and I have some guarded optimism as a result. Please bear with me because I don't know how to cut and paste. The most important paragraph related to Nicole reads as follows:
If other clinical markers of maturity such as Tanner staging or age at menarche are not consistent with the Risser grade, cuve progression may proceed at a different rate. Thus, multiple measures of maturity are important to the clinical assessment of these patients.
The average female reaches a Tanner stage 1 at 11 years, the beginning of growth spurt at 11.5, a Risser grade 1 at 12 years, and has an onset of menarche between 12 and 13 (Nicole got hers a month after her 12th b-day). A female patient who matures consistent with these averages will have a relatively higher risk of curve progression before 12 years of age (she progressed rapidly between age 11 and 12) and a relatively lower risk of curve progression after 12.5 years of age. (Please dear God, let this be true for Nicole)
I hope you don't think I am grasping for straws or trying to look through a crystal ball, but this really does describe Nicole's history of growth so far.
I am choosing to be hopeful.
Hope this wasn't too boring.
Anyway, I came across an article today from American Family Physician and I have some guarded optimism as a result. Please bear with me because I don't know how to cut and paste. The most important paragraph related to Nicole reads as follows:
If other clinical markers of maturity such as Tanner staging or age at menarche are not consistent with the Risser grade, cuve progression may proceed at a different rate. Thus, multiple measures of maturity are important to the clinical assessment of these patients.
The average female reaches a Tanner stage 1 at 11 years, the beginning of growth spurt at 11.5, a Risser grade 1 at 12 years, and has an onset of menarche between 12 and 13 (Nicole got hers a month after her 12th b-day). A female patient who matures consistent with these averages will have a relatively higher risk of curve progression before 12 years of age (she progressed rapidly between age 11 and 12) and a relatively lower risk of curve progression after 12.5 years of age. (Please dear God, let this be true for Nicole)
I hope you don't think I am grasping for straws or trying to look through a crystal ball, but this really does describe Nicole's history of growth so far.
I am choosing to be hopeful.
Hope this wasn't too boring.
Comment